Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 405

1.

T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.

Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, Lutty GA, McLeod DS.

Invest Ophthalmol Vis Sci. 1998 Apr;39(5):754-62.

PMID:
9538882
2.
3.
4.

Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.

Dick AD, McMenamin PG, K├Ârner H, Scallon BJ, Ghrayeb J, Forrester JV, Sedgwick JD.

Eur J Immunol. 1996 May;26(5):1018-25.

PMID:
8647162
5.
6.
7.
8.

Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Uchio E, Kijima M, Ishioka M, Tanaka S, Ohno S.

Graefes Arch Clin Exp Ophthalmol. 1997 Feb;235(2):97-102.

PMID:
9147958
9.

Hematopoietically derived retinal perivascular microglia initiate uveoretinitis in experimental autoimmune uveitis.

Gullapalli VK, Zhang J, Pararajasegaram G, Rao NA.

Graefes Arch Clin Exp Ophthalmol. 2000 Apr;238(4):319-25.

PMID:
10853931
10.

Antigen-presenting cells in experimental autoimmune uveoretinitis.

Ishimoto S, Zhang J, Gullapalli VK, Pararajasegaram G, Rao NA.

Exp Eye Res. 1998 Nov;67(5):539-48.

PMID:
9878216
11.
12.

Effects of experimental ocular inflammation on ocular immune privilege.

Ohta K, Wiggert B, Taylor AW, Streilein JW.

Invest Ophthalmol Vis Sci. 1999 Aug;40(9):2010-8.

PMID:
10440255
13.

Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU).

Kim MK, Caspi RR, Nussenblatt RB, Kuwabara T, Palestine AG.

Cell Immunol. 1988 Apr 1;112(2):430-6.

PMID:
2451572
14.

Pathogenic role of retinal microglia in experimental uveoretinitis.

Rao NA, Kimoto T, Zamir E, Giri R, Wang R, Ito S, Pararajasegaram G, Read RW, Wu GS.

Invest Ophthalmol Vis Sci. 2003 Jan;44(1):22-31.

PMID:
12506051
15.
16.

Antigen-directed retention of an autoimmune T-cell line.

Lightman SL, Caspi RR, Nussenblatt RB, Palestine AG.

Cell Immunol. 1987 Nov;110(1):28-34.

PMID:
2960461
17.

Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.

Kohno H, Sakai T, Saito S, Okano K, Kitahara K.

Exp Eye Res. 2007 Mar;84(3):569-76. Epub 2007 Jan 17.

PMID:
17208229
18.

Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis.

Ikeda E, Hikita N, Eto K, Mochizuki M.

Jpn J Ophthalmol. 1997 Nov-Dec;41(6):396-402.

PMID:
9509307
19.

Evidence for extrathymic generation of regulatory T cells specific for a retinal antigen.

Gregerson DS, Heuss ND, Lehmann U, McPherson SW.

Ophthalmic Res. 2008;40(3-4):154-9. doi: 10.1159/000119868. Epub 2008 Apr 18.

PMID:
18421231
20.

Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features.

Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I.

Invest Ophthalmol Vis Sci. 1985 Jan;26(1):1-9.

PMID:
3967952

Supplemental Content

Support Center